| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 1.489 | 93 | 1.709 | 597 | 2.572 | 3.008 | 4.141 |
| Total Income - EUR | - | - | - | 3.811 | 2.296 | 4.981 | 2.972 | 4.291 | 5.069 | 6.740 |
| Total Expenses - EUR | - | - | - | 2.901 | 868 | 1.008 | 2.235 | 3.098 | 4.859 | 6.478 |
| Gross Profit/Loss - EUR | - | - | - | 910 | 1.428 | 3.973 | 737 | 1.192 | 210 | 262 |
| Net Profit/Loss - EUR | - | - | - | 895 | 1.427 | 3.922 | 719 | 1.192 | 189 | 224 |
| Employees | - | - | - | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Biorosso An Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 2.240 | 4.412 | 4.971 | 4.779 | 5.111 |
| Current Assets | - | - | - | 3.351 | 4.563 | 6.584 | 4.925 | 5.573 | 6.506 | 5.040 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 1.528 | 1 |
| Receivables | - | - | - | 652 | 639 | 1.639 | 906 | 3.349 | 2.601 | 3.143 |
| Cash | - | - | - | 2.699 | 3.924 | 4.945 | 4.019 | 2.224 | 2.376 | 1.897 |
| Shareholders Funds | - | - | - | 938 | 2.348 | 6.225 | 6.806 | 8.019 | 8.184 | 8.363 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.412 | 2.216 | 2.599 | 2.532 | 2.524 | 3.100 | 1.789 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Biorosso An Srl